GB8907148D0 - Biologically active proteins - Google Patents

Biologically active proteins

Info

Publication number
GB8907148D0
GB8907148D0 GB898907148A GB8907148A GB8907148D0 GB 8907148 D0 GB8907148 D0 GB 8907148D0 GB 898907148 A GB898907148 A GB 898907148A GB 8907148 A GB8907148 A GB 8907148A GB 8907148 D0 GB8907148 D0 GB 8907148D0
Authority
GB
United Kingdom
Prior art keywords
biologically active
active proteins
proteins
biologically
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB898907148A
Other versions
GB2218101A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of GB8907148D0 publication Critical patent/GB8907148D0/en
Publication of GB2218101A publication Critical patent/GB2218101A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB8907148A 1988-03-31 1989-03-30 TNF-alpha inhibitors Withdrawn GB2218101A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807803A GB8807803D0 (en) 1988-03-31 1988-03-31 Biochemical product

Publications (2)

Publication Number Publication Date
GB8907148D0 true GB8907148D0 (en) 1989-05-10
GB2218101A GB2218101A (en) 1989-11-08

Family

ID=10634493

Family Applications (2)

Application Number Title Priority Date Filing Date
GB888807803A Pending GB8807803D0 (en) 1988-03-31 1988-03-31 Biochemical product
GB8907148A Withdrawn GB2218101A (en) 1988-03-31 1989-03-30 TNF-alpha inhibitors

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB888807803A Pending GB8807803D0 (en) 1988-03-31 1988-03-31 Biochemical product

Country Status (12)

Country Link
JP (1) JPH02117700A (en)
KR (1) KR890014125A (en)
AU (1) AU3228789A (en)
BE (1) BE1001845A4 (en)
DE (1) DE3910323A1 (en)
DK (1) DK156589A (en)
FR (1) FR2629345A1 (en)
GB (2) GB8807803D0 (en)
IL (1) IL89804A0 (en)
IT (1) IT1232827B (en)
NL (1) NL8900779A (en)
SE (1) SE8901115L (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US5811261A (en) * 1988-09-12 1998-09-22 Yeda Research And Development Co. Ltd. Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
EP0393438B1 (en) 1989-04-21 2005-02-16 Amgen Inc. TNF-receptor, TNF-binding protein and DNA coding therefor
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
IL95031A (en) * 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US5605690A (en) * 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
US5945397A (en) * 1989-09-05 1999-08-31 Immunex Corporation Purified p75 (type II) tumor necrosis factor receptor polypeptides
WO1991003553A1 (en) * 1989-09-05 1991-03-21 Immunex Corporation TUMOR NECROSIS FACTOR-α AND -β RECEPTORS
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP1132471A3 (en) 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-binding proteins
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
WO1992001002A1 (en) * 1990-07-11 1992-01-23 Teijin Limited Tumor necrosis factor activity inhibitor and production thereof
EP0480389A1 (en) * 1990-10-12 1992-04-15 Hoechst Aktiengesellschaft Inhibitors for forming tumor necrosis factor, process for their production and their use
DE69230789T3 (en) * 1991-01-18 2007-10-31 Amgen Inc., Thousand Oaks METHODS OF TREATING ILLNESSES RELEASED BY THE TUMOR NEKROSE FACTOR
WO1993004375A1 (en) * 1991-08-23 1993-03-04 Nchip, Inc. Burn-in technologies for unpackaged integrated circuits
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
JP4771563B2 (en) 1996-12-06 2011-09-14 アムジエン・インコーポレーテツド Combination therapy using IL-1 inhibitors to treat IL-1 mediated diseases
PT942740E (en) 1996-12-06 2004-01-30 Amgen Inc COMBINATION THERAPY USING A TNF LIGACTION PROTEIN FOR TREATMENT OF TNF-MEDIATED DISEASES
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
ATE464068T1 (en) 2001-06-26 2010-04-15 Amgen Fremont Inc ANTIBODIES AGAINST OPGL
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
EP1578782A4 (en) 2002-12-30 2007-09-12 Amgen Inc Combination therapy with co-stimulatory factors
US7767206B2 (en) 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
CN102821787B (en) 2010-01-15 2015-07-29 麒麟-安姆根有限公司 Antibody preparation and therapeutic scheme
WO2013016220A1 (en) 2011-07-22 2013-01-31 Amgen Inc. Il-17 receptor a is required for il-17c biology
WO2015153144A1 (en) 2014-03-31 2015-10-08 Kirin-Amgen, Inc. Methods of treating nail and scalp psoriasis

Also Published As

Publication number Publication date
IT8947794A0 (en) 1989-03-30
GB8807803D0 (en) 1988-05-05
FR2629345A1 (en) 1989-10-06
SE8901115L (en) 1989-10-01
GB2218101A (en) 1989-11-08
IT1232827B (en) 1992-03-05
NL8900779A (en) 1989-10-16
IL89804A0 (en) 1989-09-28
AU3228789A (en) 1989-10-05
DK156589D0 (en) 1989-03-30
DK156589A (en) 1989-10-01
BE1001845A4 (en) 1990-03-20
JPH02117700A (en) 1990-05-02
SE8901115D0 (en) 1989-03-30
DE3910323A1 (en) 1989-10-19
KR890014125A (en) 1989-10-21

Similar Documents

Publication Publication Date Title
IL89804A0 (en) Biologically active proteins
YU163289A (en) Recombinant animal somatotropine
HUT46539A (en) Biologically active copolimers
IL75828A (en) Immobilization by biologically active proteins
ZA895460B (en) Novel proteins
GB8517300D0 (en) Biologically active substances
HU884709D0 (en) Biologically active compounds
HUT40167A (en) Genes for biologically active proteins
GB8817161D0 (en) Modified proteins
GB8430255D0 (en) Biologically active oligopeptides
GB8816095D0 (en) Protein
EP0253245A3 (en) Biologically active peptides tan-866
IE891007L (en) Biologically active proteins
GB8806451D0 (en) Biologically active molecules
GB8809038D0 (en) Biologically active compounds
IE882193L (en) Biologically active compounds
IE881005L (en) Biologically active compounds
GB8809037D0 (en) Biologically active compounds
GB8809034D0 (en) Biologically active compounds
GB8423771D0 (en) Biologically active peptides
IL108254A0 (en) Biologically active conjugates
BG43201A1 (en) Biologically active cosmetic means
GB8615038D0 (en) Biologically active n heterocycles
GB8615040D0 (en) Biologically active n heterocycles
GB8609628D0 (en) Biologically active heterocycles

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)